Application
Western blot analysis of HSPA7 Antibody (Center) in CEM cell line lysates (35ug/lane). HSPA7 (arrow) was detected using the purified Pab.Application
Formalin-fixed and paraffin-embedded human lung carcinoma reacted with HSPA7 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | HSPA7 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | HSPA7; HSP70B; Putative heat shock 70 kDa protein 7; Heat shock 70 kDa protein B |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | HSP70B |
|---|---|
| Alternative Names | HSPA7 HSP70B Putative heat shock 70 kDa protein 7 Heat shock 70 kDa protein B |
| Molecular Weight(MW) | 40244 Da |
| Tissue Specificity | This HSPA7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 175~205 amino acids from the Center region of human HSPA7. |
Application
Western blot analysis of HSPA7 Antibody (Center) in CEM cell line lysates (35ug/lane). HSPA7 (arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human lung carcinoma reacted with HSPA7 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
